Nano-oligosaccharide factor

Nano-oligosaccharide factor (NOSF) is a carbohydrate wound exudate treatment intended to promote closure through the inhibition of matrix metalloproteinase (MMP) activity within a lipid-colloid matrix technique (LTC) produced by laboratories URGO in France. It is supplied impregnated into an absorbent sheet with an fine graticule of adhesive intended to be attached directly onto and around the wound site beneath a conventional protective dressing.[1]

See also

Dressing (medical)

References
  1. Nair, Harikrishna; Venkateshwaran, N; Seetharaman S, Selva; Deng, Wuquan; Uthaipaisanwong, Apinan; Galea, Emilio (1 April 2021). "Benefits of sucrose octasulfate (TLC-NOSF) dressings in the treatment of chronic wounds: a systematic review". Journal of Wound Care. 30 (Sup4): S42–S52. doi:10.12968/jowc.2021.30.Sup4.S42.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.